In the March issue of PME we hear from AbbVie’s UK general manager Matt Regan, who tells us how its culture has been evolving since the business’ 2013 split from Abbott.
Ken Jones from Astellas talks to us about how his company is looking at ‘borderless innovation’ and Pierre Chanel and Riccardo Perfetti give us their thoughts on Sanofi’s latest mHealth initiative.
This month we ask whether the end of hepatitis C is nigh – and if so, will access prove to be pharma’s next challenge in this rapidly-moving therapy area?
There’s a focus too on social media ‘listening’ and in Darwin’s Medicine Professor Brian D Smith says it’s time for life science firms to prioritise their response to market changes.
Also with this issue are our Patients First supplement, produced in association with Engage, and the next in the Heart of the Matter thought leadership series from McCann Complete Medical.
Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.
PME is also available to download as an app for iPhone and iPad
